Latest stories on IGC
IGC Pharma GAAP EPS of -$0.03 misses by $0.01, revenue of $0.27M beats by $0.17M
Seeking Alpha48 · neutralearnings
IGC Pharma sees cash runway for 12 months from quarterly report filing date
The Fly50 · neutralgeneral
IGC Pharma reports Q2 EPS (3c) vs. (2c) last year
The Fly56 · neutralearnings
IGC Pharma Reports Q2 2026 Results as CALMA Alzheimer's Trial Moves Within Six Randomizations of Enrollment Closure
StockTitan58 · neutralearnings
IGC Pharma strengthens regulatory readiness of Phase 2 CALMA trial
The Fly59 · neutralproduct/pr
IGC Pharma, Inc. (IGC) files 8-K
SEC 8-K50 · neutralgeneral
IGC Pharma CEO, finance chief buy $1.15M of common stock
Seeking Alpha71 · bullishgeneral
IGC Pharma Executives Convert Debt Into Equity Shares
TipRanks52 · neutralgeneral
IGC Pharma, Inc. (IGC) files 8-K
SEC 8-K50 · neutralgeneral
IGC Pharma Extends and Amends $12 Million Loan Facility
TipRanks42 · neutralgeneral
IGC Pharma, Inc. (IGC) files 8-K
SEC 8-K50 · neutralgeneral
IGC Pharma Adds Mount Sinai Clinical Site as CALMA Trial Advances Toward Completion and Topline Analysis | IGC Stock News
StockTitan63 · neutralproduct/pr
IGC Pharma Reports First Quarter 2026 Financial Results with CALMA Phase 2 in the final stage, with 80% Enrollment
Morningstar63 · neutralproduct/pr